证券代码：002326 证券简称：永太科技 公告编号：2023-063 注：浙江永太控股有限公司、上海阿杏投资管理有限公司－阿杏格致12号私募证券投资基金的持股数 量未包含其因开展转融通证券出借业务尚未收回的部分，前述转融通证券出借业务所涉及的股份不发生所 有权转移。 浙江永太科技股份有限公司 关于控股股东部分股权质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江永太科技股份有限公司（以下简称"公司"）近日接到控股股东王莺妹 女士的通知，获悉王莺妹女士所持有的本公司部分股权进行了质押。具体事项如 下： | 股东 | 是否为第一 大股东及一 | | 本次质押数 | 占其所持股 | 占公司总股 | 是否为 | 是否为补 | 质押 | 质押 | 质权人 | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | | | 量（万股） | 份比例(%) | 本比例(%) | 限售股 | 充质押 | 开始日 | 到期日 | | 用途 | | | ...

证券代码：002326 证券简称：永太科技 公告编号：2023-064 浙江永太科技股份有限公司 关于子公司诺氟沙星胶囊通过仿制药一致性评价的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江永太科技股份有限公司（以下简称"公司"）的控股子公司佛山手心制 药有限公司于近日收到国家药品监督管理局核准签发的化学药品诺氟沙星胶囊 的《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价（以 下简称"一致性评价"）。现将有关情况公告如下： 一、药品的基本情况 药品名称：诺氟沙星胶囊 英文名/拉丁名：Norfloxacin Capsules 剂型：胶囊剂 规格：0.1g 注册分类：化学药品 原药品批准文号：国药准字 H44021212 药品注册标准编号：YBH14932023 上市许可持有人和生产企业：佛山手心制药有限公司 审批结论：根据《中华人民共和国药品管理法》《国务院关于改革药品医疗 器械审评审批制度的意见》（国发〔2015〕44 号）和《关于仿制药质量和疗效一 致性评价工作有关事项的公告》（2017 年第 100 号）的规定，经审查，本品视同 ...

变更前注册资本：捌亿柒仟陆佰伍拾陆万陆仟贰佰玖拾伍元 变更后注册资本：玖亿壹仟叁佰柒拾陆万零柒佰玖拾伍元 证券代码：002326 证券简称：永太科技 公告编号：2023-062 浙江永太科技股份有限公司 关于完成增加注册资本工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 鉴于浙江永太科技股份有限公司（以下简称"公司"）已完成发行全球存托 凭证（Global Depository Receipts）并于2023年7月11日（伦敦时间）在伦敦 证券交易所上市，公司于2023年9月20日召开2023年第一次临时股东大会，审议 通过了《关于变更公司注册资本及修改<公司章程>的议案》，公司注册资本由 876,566,295元变更为913,760,795元，公司股本总数由876,566,295股变更为 913,760,795股。《公司章程》及修订具体内容详见公司于2023年7月13日在《 证 券 时 报 》 《 上 海 证 券 报 》 《 证 券 日 报 》 及 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露的相关公告。 ...

上海市锦天城律师事务所 关于浙江永太科技股份有限公司 2023 年第一次临时股东大会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 楼 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于浙江永太科技股份有限公司 2023 年第一次临时股东大会的 法律意见书 （二）本次股东大会的召开 致：浙江永太科技股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受浙江永太科技股份有限 公司（以下简称"公司"或"永太科技"）委托，就公司召开 2023 年第一次临 时股东大会（以下简称"本次股东大会"）的有关事宜，根据《中华人民共和国 公司法》（以下简称《公司法》）《上市公司股东大会规则》等法律、法规、规 章和其他规范性文件以及《浙江永太科技股份有限公司章程》（以下简称《公司 章程》）的有关规定，出具本法律意见书。 （一）本次股东大会的召集 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定 ...

证券代码：002326 证券简称：永太科技 公告编号：2023-061 浙江永太科技股份有限公司 2023 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 1、本次股东大会召开期间没有否决议案的情况发生。 2、本次股东大会不涉及变更前次股东大会决议的情况。 3、会议召开方式：现场会议与网络投票相结合的方式。 4、会议召集人：公司董事会。 5、会议主持人：本次会议由董事长王莺妹女士主持。 一、会议召开和出席情况 （一）会议召开情况 1、召开时间 （1）现场召开时间：2023 年 9 月 20 日（星期三）14:30； （2）网络投票时间：2023 年 9 月 20 日； 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2023 年 9 月 20 日 9:15 至 9:25，9:30 至 11:30, 13:00 至 15:00； 通过深圳证券交易所互联网投票的具体时间为 2023 年 9 月 20 日 9:15 至 15:00 期间的任意时间。 2、现场会议召开地点：浙江省化学原料药基地临海园区东海第四大道 1 ...

证券代码：002326 证券简称：永太科技 公告编号：2023-060 浙江永太科技股份有限公司 | | | | 本次质押及 | 本次质押及 | 占其所 | 占公司 | 已质押股份情况 | | 未质押股份情况 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 持股数量 | 持股比 | 解除质押前 | 解除质押后 | 持股份 | 总股本 | 已质押股份限 | 占已质 | 未质押股份 | 占未质 | | 名称 | （万股） | 例（%） | 质押股份数 | 质押股份数 | 比例（%） | 比例 | 售和冻结数量 | 押股份 | 限售和冻结 | 押股份 | | | | | 量（万股） | 量（万股） | | （%） | （万股） | 比例（%） | 数量（万股） | 比例（%） | | 王莺妹 | 14,424.84 | 15.79 | 4,915.80 | 5,865.80 | 40.66 | 6.42 | 5,865.80 | 100.00 | 4,952.83 | 57.87 | | 何人宝 | 11, ...

Financial Performance - Total operating revenue for the first half of 2023 was ¥2,053,255,250.17, a decrease of 38.1% compared to ¥3,316,898,537.85 in the same period of 2022[25] - The net comprehensive income attributable to the parent company was ¥29,703,057.57, down from ¥496,366,696.10 in the previous year[27] - Basic and diluted earnings per share for the first half of 2023 were both ¥0.04, compared to ¥0.56 in the same period of 2022[27] - The company reported a significant decrease in comprehensive income, totaling ¥4,209,590.20 for the first half of 2023, compared to ¥566,755,028.84 in the same period of 2022[27] - The company's operating revenue for the first half of 2023 was ¥735.65 million, a decrease of 33.2% compared to ¥1,101.85 million in the same period of 2022[55] - Operating profit for the first half of 2023 was ¥109.98 million, down 14.4% from ¥128.56 million in the first half of 2022[56] - The net profit for the first half of 2023 increased to ¥113.16 million, up 9.9% from ¥103.06 million in the same period of 2022[56] - The total comprehensive income for the first half of 2023 is approximately 113.16 million RMB[67] Cash Flow and Investments - The net cash outflow from operating activities was CNY 202.5 million, a significant decrease from a net inflow of CNY 467.4 million in the same period last year, representing a decline of approximately 143.3%[30] - Cash inflow from investment activities totaled CNY 133.5 million, down from CNY 198.2 million in the previous year, reflecting a decrease of about 32.6%[30] - The net cash outflow from investment activities was CNY 170.6 million, an improvement compared to a net outflow of CNY 450.0 million in the same period last year, indicating a reduction of approximately 62.0%[30] - Cash inflow from financing activities increased to CNY 1.98 billion, compared to CNY 1.34 billion in the previous year, marking a growth of approximately 47.8%[30] - The net cash flow from financing activities was CNY 434.2 million, a significant increase from CNY 123.8 million in the same period last year, representing a growth of about 250.0%[30] - The total cash and cash equivalents at the end of the period amounted to CNY 493.5 million, a decrease from CNY 522.1 million at the end of the previous year, reflecting a decline of approximately 5.5%[30] - The company reported cash inflow from financing activities of ¥1,221.73 million, an increase of 26.0% from ¥968.95 million in the same period of 2022[59] Shareholder Information - The total number of shares outstanding as of the report date was 876,566,295, with 12.52% being restricted shares[11] - The company experienced a reduction of 119,522,234 restricted shares, resulting in a new total of 109,727,860 restricted shares[11] - The number of shareholders holding more than 5% of ordinary shares was 143,409 as of the report date[14] - As of June 30, 2023, the total issued share capital of the company is 876,566,295 shares, with a registered capital of 876,566,295 yuan[41] - The company has a total share capital of 876.57 million RMB as of June 30, 2023[67] Assets and Liabilities - The company's total assets as of June 30, 2023, amount to 4,300,161,402.20 yuan, a decrease from 4,468,216,615.57 yuan at the beginning of the year[49] - The company's inventory as of June 30, 2023, is 1,722,688,867.75 yuan, an increase from 1,656,002,531.68 yuan at the beginning of the year, reflecting a growth of approximately 4.0%[49] - The company's cash and cash equivalents as of June 30, 2023, are 913,836,684.15 yuan, down from 959,294,353.56 yuan at the beginning of the year, indicating a decrease of about 4.7%[49] - The company's accounts receivable as of June 30, 2023, stand at 911,323,787.80 yuan, down from 1,097,584,586.54 yuan at the beginning of the year, representing a decline of approximately 17.0%[49] Research and Development - Research and development expenses increased to ¥42.91 million, up 29.5% from ¥33.14 million in the first half of 2022[55] Compliance and Governance - The company did not report any major related party transactions during the reporting period[1] - The company has not undergone any changes in its actual controller during the reporting period[45] - The company has not issued any preferred shares during the reporting period[46] - The company has not engaged in any repurchase transactions by its top shareholders during the reporting period[43] - The financial report is guaranteed to be true, accurate, and complete by the company's responsible personnel[195] - The company has disclosed all original documents and announcements during the reporting period[199] Accounting Policies - The financial statements are presented in RMB, adhering to the enterprise accounting standards[77] - The financial statements were prepared in accordance with the accounting standards issued by the Ministry of Finance, ensuring a true and complete reflection of the company's financial status as of June 30, 2023[96] - The company applies specific accounting policies for bad debt provisions, fixed asset depreciation, and revenue recognition based on its operational characteristics[95] - The company recognizes goodwill when the acquisition cost exceeds the fair value of identifiable net assets acquired in a business combination[99] - The company ensures that internal transactions between itself and subsidiaries are eliminated in the consolidated financial statements[101] - The company has established a financial asset classification system based on its business model and cash flow characteristics[107] - The company’s financial reporting adheres to the guidelines set forth by the China Securities Regulatory Commission, ensuring compliance with disclosure requirements[92] Future Plans - The company plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves[196]

证券代码：002326 证券简称：永太科技 公告编号：2023-054 浙江永太科技股份有限公司 关于控股股东部分股权质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江永太科技股份有限公司（以下简称"公司"）近日接到控股股东何人宝 先生的通知，获悉何人宝先生所持有本公司的部分股权进行了质押。具体事项如 下： 一、股东股份本次质押基本情况 | 股东 | 是否为第一 大股东及一 | | 本次质押数 | 占其所持股 | 占公司总股 | 是否为 | 是否为补 | 质押 | 质押 | 质权人 | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | | | 量（万股） | 份比例(%) | 本比例(%) | 限售股 | 充质押 | 开始日 | 到期日 | | 用途 | | | 致行动人 | | | | | | | | | | | | 何人宝 | | 是 | 90.60 | 0.81 | 0.10 | 否 | 是 | 2023-08-15 | ...

浙江永太科技股份有限公司投资者关系活动 记录表 编号：2023-04 | --- | --- | --- | |----------------------|----------------------------------|--------------------------------------------------| | | | | | | 特定对象调研 | 分析师会议 | | 投资者关系活动类别 | 媒体采访 | 业绩说明会 | | | 新闻发布会 | 路演活动 | | | 现场参观 | 其他 | | 活动参与人员 | 公司董事长：王莺妹 | | | | 独立董事：许永斌 | | | | 董事、副总经理、财务总监：陈丽洁 | | | | 董事会秘书、副总经理：张江山 | | | | 通过全景网"投资者关系互动平台"（ | https://ir.p5w.net ） | | | 参与业绩说明会的投资者 | | | | | | | 时间 | 2023 年 5 月 5 日 | （周五） 15:00-17:00 | | | | | | 地点 | 网络平台 | | | 形式 | 线上交流 | | | | | ...

Financial Performance - The company reported a 42.10% year-over-year decline in operating revenue, totaling approximately ¥1,005.91 million for the first quarter of 2023, compared to ¥1,737.30 million in the same period last year[14]. - Net profit attributable to shareholders decreased by 93.51% year-over-year, amounting to approximately ¥43.42 million, down from ¥517.37 million in the previous year[14]. - The net profit excluding non-recurring items fell by 97.49% year-over-year, indicating significant operational challenges during the reporting period[6]. - The company's overall gross margin and gross profit for the reporting period were 24.81% and 249.55 million yuan, respectively, down significantly from 40.26% and 699.48 million yuan in the same period last year[19]. - Operating revenue decreased by 42.10% due to a decline in sales of lithium battery and trading products[21]. - Net profit decreased by 96.10%, attributed to the decline in gross margin leading to reduced profits[21]. - The basic earnings per share for Q1 2023 was ¥0.029, down 93.48% from ¥0.445 in the same period last year[59]. - The weighted average return on equity decreased to 0.74%, down 9.76 percentage points from 10.50% year-on-year[59]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 57.35% due to reduced sales collections and increased material payments[39]. - The company's cash and cash equivalents at the end of the reporting period were approximately 881.40 million yuan, down from 959.29 million yuan at the beginning of the year[25]. - Total operating cash inflow for Q1 2023 was CNY 1,074,971,411.23, a decrease of 22.5% compared to CNY 1,387,970,763.24 in the same period last year[104]. - Net cash generated from operating activities was CNY 151,094,627.53, down 57.4% from CNY 354,261,293.85 in Q1 2022[104]. - Cash received from other operating activities was CNY 33,549,224.61, a decline from CNY 42,238,538.56 year-over-year[104]. - Total cash outflow from operating activities was CNY 923,876,783.70, compared to CNY 1,033,709,469.39 in the same quarter last year[104]. - Cash received from investment recovery was CNY 35,000,000.00, significantly lower than CNY 123,289,057.14 in Q1 2022[104]. - Cash paid for investments was CNY 25,000,000.00, up from CNY 19,000,000.00 in the previous year[104]. Assets and Liabilities - The company's total assets increased to approximately ¥11.58 billion, up from ¥11.35 billion at the beginning of the year, reflecting a growth of 2.01%[13]. - The total liabilities of the company increased to approximately 7.82 billion yuan from 7.61 billion yuan at the beginning of the year[44]. - The total liabilities and shareholders' equity amounted to approximately ¥11.58 billion, indicating a stable financial position despite the operational downturn[13]. - Long-term borrowings rose by 41.84% to approximately ¥3.16 billion, attributed to increased bank loans during the reporting period[7]. Investments and Subsidiaries - The company established a joint venture, Zhejiang Yongtai Fluorine Technology Co., Ltd., with an investment of ¥96 million, representing an 80% stake[10]. - A wholly-owned subsidiary, Shandong Yonghong Lithium Technology Co., Ltd., was established with an investment of ¥100 million to support future business development[10]. - The company plans to establish a joint venture, Fujian Yongtai Fluorine Source Technology Co., Ltd., with an investment of ¥97.5 million, representing a 65% stake[81]. Research and Development - Research and development expenses for the quarter were approximately ¥35.54 million, slightly up from ¥34.25 million in the previous year, indicating continued investment in innovation[14]. Financial Management - The company reported a significant increase in special reserves by 86.41%, reflecting proactive financial management strategies[7]. - Financial expenses increased by 35.98% due to increased exchange losses during the reporting period[21]. - The company received government subsidies, leading to a 2464.55% increase in other income[21]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 153,302[22]. - The company reported a net increase in cash and cash equivalents of ¥7,896,831.42 for Q1 2023, compared to an increase of ¥45,934,874.80 in the same period last year[55].